Original language | English |
---|---|
Article number | 114 |
Number of pages | 7 |
Journal | BMC Psychiatry |
Volume | 13 |
DOIs | |
Publication status | Published - 15 Apr 2013 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: BMC Psychiatry, Vol. 13, 114, 15.04.2013.
Research output: Contribution to journal › Article › Other
TY - JOUR
T1 - A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): study protocol
AU - O'Neil, Adrienne
AU - Berk, Michael
AU - Itsiopoulos, Catherine
AU - Castle, David
AU - Opie, Rachelle
AU - Pizzinga, Josephine
AU - Brazionis, Laima
AU - Hodge, Allison
AU - Mihalopoulos, Catherine
AU - Chatterton, Mary Lou
AU - Dean, Olivia
AU - Jacka, Felice N
N1 - Funding Information: This study is funded by a National Health and Medical Research Council (NHMRC) project grant (#1021347). AO and FNJ are supported by Early Career Fellowships (ECF) from the NHMRC (#1052865; 628912). OMD is an Alfred Deakin Postdoctoral Research Fellow. The authors would like to thank the project team; Sarah Dash, Melanie Ashton, Laura Nicholls and Thea Vakidis, staff at the respective study sites (St Vincent’s and Barwon Health) and all study participants. We acknowledge the support of Woolworths supermarkets and Carman’s muesli for the provision of food items. Funding Information: MB has received Grant/Research Support from the NIH, Simons Foundation, CRC for Mental Health, Stanley Medical Research Institute, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier and Astra Zeneca. He has been a paid consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Pfizer and a paid speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi Synthelabo, Solvay and Wyeth. OMD has received grant support from the Brain and Behavior Foundation, Simons Autism Foundation, Stanley Medical Research Institute, Lilly, NHMRC and an ASBD/Servier grant. FNJ has received Grant/Research support from the Brain and Behaviour Research Institute, the National Health and Medical Research Council, Australian Rotary Health, the Geelong Medical Research Foundation, the Ian Potter Foundation, Eli Lilly and The University of Melbourne and has been a paid speaker for Sanofi-Synthelabo, Janssen Cilag and Eli Lilly.
PY - 2013/4/15
Y1 - 2013/4/15
UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636120/pdf/1471-244X-13-114.pdf
UR - http://www.scopus.com/inward/record.url?scp=84876132602&partnerID=8YFLogxK
U2 - 10.1186/1471-244X-13-114
DO - 10.1186/1471-244X-13-114
M3 - Article
C2 - 23587364
SN - 1471-244X
VL - 13
JO - BMC Psychiatry
JF - BMC Psychiatry
M1 - 114
ER -